More

    MK Hamied steps down as Cipla’s Vice Chairman on account of age, health | Company News


    Cipla plans acquisitions to take top spot in South Africa drug market

    The company said the board has also approved the appointment of Kamil Hamied as Non-Executive Director.


    Drug major Cipla on Tuesday said MK Hamied has resigned as Vice Chairman with effect from October 29 due to age and health.


    “It is with a heavy heart that I write to formally announce my resignation from the position of Vice Chairman and Non-Executive Director of the company,” he said in a letter to the board of directors.


    The company said the board has also approved the appointment of Kamil Hamied as Non-Executive Director, with effect November 1, 2024.


    “I am pleased to see that Kamil Hamied will be joining the Board as a Non-Executive Director to maintain continuity while representing the promoter family,” MK Hamied said in the letter.

    First Published: Sep 03 2024 | 11:27 PM IST



    Source link

    Latest articles

    Related articles

    Discover more from Blog | News | Travel

    Subscribe now to keep reading and get access to the full archive.

    Continue reading